Psychophysiological effects of heart rate variability biofeedback versus sham biofeedback: A randomized controlled trial.

OBJECTIVE

Heart rate variability biofeedback (HRV-BFB) is a nonpharmacological treatment used to improve both autonomic nervous system (ANS) functioning and mental health. Nevertheless, evidence-based approaches are needed to demonstrate that HRV-BFB effects are over and above the placebo effect. Further evidence of its efficacy during emotional tasks is also required. The aim of our randomized controlled trial was therefore to examine HRV-BFB effects on the psychophysiological states of healthy adults against a valid sham condition.

METHOD: Participants (N = 47) underwent three assessments spaced 24 days apart. Psychological states were estimated (affectivity, anxiety, depression, perceived stress, coping, life satisfaction). Aspects of ANS activity (HRV, electrodermal activity) were then recorded at rest, in reactivity during an overload mental task, and in recovery from it. After a 24-day pre-training period, participants were randomly assigned to either the HRV-BFB group (n = 24, Mage = 35.00, five males) or the sham HRV-BFB group (n = 23, Mage = 28.00, five males) and had to practice daily for 5 min, three times a day, during a 24-day training period.

RESULTS

HRV-BFB improved positive affectivity and reduced depression in comparison with sham HRV-BFB, but did not modulate ANS (rest / reactivity / recovery). Exploratory analyses indicated that a higher respiratory-mediated HRV during HRV-BFB practice did not systematically correspond to maximized psychological benefits.

CONCLUSION

The effects of HRV-BFB are greater than those of sham HRV-BFB for reducing psychological distress. We discuss potential mechanisms underlying HRV-BFB's benefits and its relevance as an evidence-based nonpharmacological treatment.